Difficulty: Medium
Average Score: 92%
Practice
Metabolic derangement secondary to tumor lysis syndrome in children includes all the following EXCEPT
Correct answer
B
Rationale
In the context of tumor lysis syndrome (TLS) in children, metabolic derangements commonly occur due to the rapid release of intracellular contents into the bloodstream following cancer treatment. The correct answer, B) hypernatremia, is not typically associated with TLS in children. The rationale behind this is that hypernatremia refers to elevated levels of sodium in the blood, which are not typically a direct result of tumor lysis.
A) Hyperuricemia is a common feature of TLS as a result of the breakdown of nucleic acids from rapidly proliferating cells, leading to elevated uric acid levels in the blood. C) Hyperkalemia is also a common finding in TLS due to the release of potassium from lysed cells, which can lead to potentially life-threatening cardiac arrhythmias. D) Hyperphosphatemia occurs due to the release of phosphate from broken-down cells and can lead to complications such as hypocalcemia and renal damage.
In an educational context, understanding the metabolic derangements associated with TLS is crucial for healthcare providers caring for pediatric patients undergoing cancer treatment. Recognizing these abnormalities promptly and implementing appropriate interventions can help prevent serious complications and improve patient outcomes. Educating healthcare professionals about the signs, symptoms, and management of TLS in children is essential for providing safe and effective care in pediatric oncology settings.
A) Hyperuricemia is a common feature of TLS as a result of the breakdown of nucleic acids from rapidly proliferating cells, leading to elevated uric acid levels in the blood. C) Hyperkalemia is also a common finding in TLS due to the release of potassium from lysed cells, which can lead to potentially life-threatening cardiac arrhythmias. D) Hyperphosphatemia occurs due to the release of phosphate from broken-down cells and can lead to complications such as hypocalcemia and renal damage.
In an educational context, understanding the metabolic derangements associated with TLS is crucial for healthcare providers caring for pediatric patients undergoing cancer treatment. Recognizing these abnormalities promptly and implementing appropriate interventions can help prevent serious complications and improve patient outcomes. Educating healthcare professionals about the signs, symptoms, and management of TLS in children is essential for providing safe and effective care in pediatric oncology settings.